In the BioHarmony Drug Report Database

Persantine (dipyridamole) is a small molecule pharmaceutical. Dipyridamole was first approved as Persantine on 1986-12-22. The pharmaceutical is active against equilibrative nucleoside transporter 1. In addition, it is known to target high affinity cAMP-specific and IBMX-insensitive 3′,5′-cyclic phosphodiesterase 8A, high affinity cAMP-specific and IBMX-insensitive 3′,5′-cyclic phosphodiesterase 8B, equilibrative nucleoside transporter 4, and cAMP-specific 3′,5′-cyclic phosphodiesterase 7B.